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106ABSTRACT
The shortage of organs leads to the need for utilizing suboptimal kidneys for trans-
plantation. The distinction between optimal, marginal, and suboptimal kidneys leads sur-
geons to face not only technical problems but also ethical and legal issues related to clinical
advantages offered by the transplant of a nonstandard kidney and the acquisition of con-
sent. Between 1999 and 2015, we performed 658 transplants, 49 (7.5%) using suboptimal
kidneys. All patients were alive and with vital graft throughout follow-up. We did not
encounter any major surgical complications. From a technical point of view, our experience
and literature review conﬁrm that transplant of suboptimal kidney leads to good clinical
results but exposes patients to a increased risks of surgical complications. Therefore, these
interventions must take place in hospitals fully prepared for this type of surgery and per-
formed by experienced transplant surgeons with proper matching between organ and
recipient. Considering the insufﬁcient resources available, from an ethical and legal point
of view, doctors play an essential role in optimizing the use of these kidneys by avoiding
wastage of organs, ensuring that transplants are done in suitable patients, and that patients
are fully informed and aware of the risks and beneﬁts associated with the speciﬁc subop-
timal kidney being transplanted. We believe that, in highly specialized centers, the number
of suboptimal kidney transplants should be increased, as their use has shown good clinical
results and carries fewer ethical issues compared with marginal kidneys. Further, subop-
timal kidneys may also be proposed for use in young patients with end-stage renal disease.*Address correspondence to Paola Incollingo, MD, Operative
Unit of General Surgery and Kidney Transplant Unit, Advanced
Biomedical Science Department, University Federico II of Naples,
Via S. Pansini 5, 80131 Naples, Italy. E-mail: paolaincollingo@
hotmail.itSINCE the ﬁrst kidney transplant took place in 1954,enormous progress has been made in surgical out-
comes and immunosuppressive therapy. Thus, kidney
transplantation has become the most effective treatment for
end-stage renal disease (ESRD).
In Italy, as of December 31, 2015, there were 9070 pa-
tients on the waiting list for all organ transplants and, of
these, 6765 patients were awaiting kidney transplantation
(76%). As of January 1, 2015, 6906 patients were on the
kidney transplant waiting list, and throughout the year a
further 1897 patients were added, totaling 8803 patients.
There were 2038 patients removed from the waiting list,
but only 1576 of these were because they actually received
a kidney transplant. The others were removed because
they either died or presented with clinical changes8
rg/10.1016/j.transproceed.2018.05.031contraindicating transplantation. The mean waiting period
for a kidney transplant was 2.4 years, with a mortality rate
of 1.6% [1].
The data just presented show that the number of kidneys
available in Italy has not satisﬁed the need for organs and,
therefore, throughout the year, the number of patients on
the kidney transplant waiting list has remained stable. The
situation has been similar worldwide.ª 2018 Elsevier Inc. All rights reserved.
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SUBOPTIMAL KIDNEYS 107Italian legislation regarding cadaveric organ donation
permits the harvesting of organs only from patients who,
during their lifetime, expressed their intention to donate
organs or, in cases of unexpressed denial, if the patient’s
relatives express consent to donation. This led to a shortage
of organ donations. Therefore, to expand the donor pool, it
has become necessary to utilize marginal donor organs.
Generally, a kidney is considered marginal when har-
vested from a donor >60 years old, or those between 50 and
59 years with 2 of the following characteristics: cerebro-
vascular accident as cause of death, hypertension, serum
creatinine >1.5 mg/dL, and, more generically, a kidney with
qualitatively reduced working parenchyma [2,3].
As ethical and legal issues related to nonstandard kidneys
have been considered and dealt with, the utilization of
marginal kidneys is now accepted for certain patients,
particularly elderly patients [4,5].
There is a subcategory of marginal kidneys, called sub-
optimal kidneys, with intermediate features between stan-
dard and marginal kidneys. Suboptimal kidneys are organs
that, although harvested from a standard donor, present
complex arterial anomalies (>2 arteries, although with a
single patch or separated so as to require a double anasto-
mosis or bench reconstruction); parenchymal damage, such
as focal sclerosis areas or sutured polar branches acciden-
tally damaged during organ harvest; or complex anomalies
of the excretory tract (complete double district), which can
lead to a quantitatively but not qualitatively reduced
nephron mass [6].
The lack of organ donation and the beneﬁts trans-
plantation can provide to patients in ESRD are the main
reasons why suboptimal kidneys have come into use. OurTable 1. Characteristics of
Donors
Anatomic abnormality Kidneys with:
(a) 4 arteries: 3 pts
(b) 3 arteries on single patch: 8
(c) 2 arteries on separate patch
(d) Reconstructed transected po
(e) Tied polar branch: 4 pts
(f) Complete urinary double dist
Cause of death Trauma 9 pts
Cerebrovascular accidents 40 p
Female 15 pts (1aþ3bþ5cþ2dþ1eþ3f)
Male 34 pts (2aþ5bþ12cþ7dþ3eþ5f
Age 40 y 10 pts (2aþ1bþ5cþ1dþ1f)
Age 41e55 y 33 pts (1aþ6bþ10cþ7dþ3eþ6f
Age 56 y 6 pts (1bþ2cþ1dþ1eþ1f)
eGFR 50 d
eGFR 51e80 18 pts (2aþ6bþ6cþ1dþ1eþ2f)
eGFR >80 31 pts (1aþ2bþ11cþ8dþ3eþ6f
Diabetes d
Hypertension 15 pts
BMI >31 14 pts
Abbreviations: BMI, body mass index; eGFR, estimated glomerular ﬁltration rate; p
*Three-year follow-up. No recipient had anatomic abnormalities or major comorbidgoal in this study was to highlight some of the ethical
problems related to use or nonuse of suboptimal kidneys for
transplant.
MATERIALS AND METHODS
Between January 1999 and December 2015, 658 kidney transplants
from cadaveric donors were performed in our transplant unit, with
49 (7.5%) of these being suboptimal organs.
Patients transplanted with a suboptimal kidney, in addition to
being on the standard waiting list, were placed on a waiting list
dedicated only to patients who gave consent to receive a suboptimal
kidney. These patients were fully informed regarding the risks
associated with suboptimal kidney utilization. This information was
provided at the time of enrollment onto the waiting list and
reviewed on the day of transplant. On both occasions, patients
signed a speciﬁc consent document.
Of the 49 suboptimal kidneys, 3 had 4 arteries, 8 had 3 arteries on
a single patch, 17 had 2 separate arteries with small separate
patches sequentially anastomosed, 9 had a transected polar branch
reconstructed on a single aortic patch together with the main artery,
4 had a polar branch tied, and 8 had a complete urinary double
district (Table 1 and Fig 1).
RESULTS
All suboptimal kidneys transplanted in our transplant unit
showed good renal function with creatinine levels ranging
from 0.8 to 2.5 mg/dL, reached within 20 days. All patients
were alive and with a vital graft during the follow-up period
(range, 24e60 months). We had no major complications
(Table 2) and patients were satisﬁed with the clinical results.
After transplant, none of our patients complained about
incorrect or incomplete information on consent and neitherDonors and Recipients
Recipients*
pts
: 17 pts
lar branch: 9 pts
rict: 8 pts
d
ts
d
d
38 pts (2aþ6bþ14cþ8dþ3eþ5f)
) 11 pts (1aþ2bþ3cþ1dþ1eþ3f)
9 pts (6cþ1dþ2f)
) 29 pts (3aþ7bþ4cþ7dþ3eþ5f)
11 pts (1bþ7cþ1dþ1eþ1f)
36 pts (3aþ7bþ10cþ9dþ4eþ3f)
13 pts (1bþ7cþ5f)
) /
4 pts
39 pts
/
t, patient; y, year.
ities other than diabetes and hypertension.
Fig 1. Reconstruction of a polar branch.
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action from patients.
Ethical Considerations
It may seem evident and fair that all patients in ESRD
should receive optimal kidneys, but unfortunately this is not
possible. Thus, the lack of available donors makes use of
suboptimal kidneys necessary.
Transplant of a suboptimal kidneyda kidney with a
quantitatively but not qualitatively reduced amount of
working parenchymadpresents more technical difﬁculties
than a standard organ transplant and exposes the patient to
a higher risk of surgical complications [7e11]. Use of sub-
optimal kidneys may be associated with a higher risk of graft
loss and morbidity and mortality of patients, so their use
requires experienced surgeons [12e16].
Justiﬁcation for the utilization of suboptimal kidneys
comes from the fact that, even if not ideal, it offers the
ESRD patient a better quality of life and longer survival
than dialysis. To not make use of suboptimal kidneys may
also potentially affect the chances of many patients to ever
receive a transplant [17].
It may seem ethically questionable to transplant a sub-
optimal organ that may lead to the need for graft ne-
phrectomy and return of the patient to the waiting list, with
enhanced technical difﬁculties in a further transplant along
with immunologic sensitization; however, suboptimal organ
utilization can be considered a better alternative to dialysis
or death while waiting for a transplant [18e21]. We mustTable 2. Complications Occur
Number of Kidneys
3 kidneys with 2 arteries of similar gauge with small
separate patches
Showed a
did not a
1 kidney with a complete double district Presented
4 kidneys with polar branch accidently tied Manifested
functiona
1 kidney with 4 arteries Showed aalso consider that even a transplant with an optimal kidney
could result in early loss of the graft, so not using a sub-
optimal kidney could imply condemning a patient to death
while waiting for the perfect organ that may never materi-
alize; indeed, even if the ideal organ does become available,
there is no guarantee the transplant would succeed. Further,
using a suboptimal kidney does not necessarily mean there
would be early graft loss [22].
Consent plays a very important role in the process leading
up to transplant of a suboptimal kidney. For consent to be
considered valid, it is necessary to provide the patient with
full, comprehensive, accurate information relating to
receiving a suboptimal kidney, including all beneﬁts and
risks. If any information provided were found to be insuf-
ﬁcient, falsiﬁed, or omitted, consent would be deemed
vitiated and invalid [23,24].
Negligent information before consent may also lead to civil
and penal action against the surgeon. If not correctly informed,
the recipient could claim indemnity for damages in the case of
earlier loss of the graft, as compared with prediction of the
organ’s survival for optimal kidney transplant [25,26].
The recipient must be sufﬁciently informed about the
transplant of a suboptimal kidney and all implications of
graft survival so that an informed, autonomous decision can
be made whether to accept or refuse the procedure. The
doctors involved are forbidden to omit information relating
to suboptimal kidney utilization even when they consider
this to be in the interest of the patient and that it may result
in the possibility of the recipient refusal [27,28].red in Our Transplant Unit
Complications
thrombosis of the smaller branch that caused a localized infarct that
ffect the early functional recovery
leakage on postoperative day 7, treated with a conservative therapy
an ischemic zone during the reperfusion that did not affect the
l recovery
thrombosis of 2 of the 4 branches at 6 months posttransplant
SUBOPTIMAL KIDNEYS 109The unpredictability of when an organ will become
available is the reason why a potential recipient should be
informed on the opportunity to receive a suboptimal kidney
when placed on the waiting list, so as to provide the op-
portunity to express in advance the will to accept or refuse
the organ [29]. This question should be asked again to the
recipient, even at the time the transplant, highlighting the
speciﬁc characteristics that make that speciﬁc kidney a
suboptimal organ and the particular additional risks linked
to that organ. So, the patient has the right to change his/her
decision at any point up until the surgery takes place.
In our experience, the respect of all the points previously
listed and the sign of the consent occurred in the way
explained above, lead: on the ethical side, to the utilization
of suboptimal kidneys only in correctly informed patients
and conscious of the beneﬁt and risks related to the utili-
zation of those organs; on the legal side, to the absence of
legal claims. We did not incur in any legal action as the
suboptimal kidney transplants we performed showed good
clinical results, so there was no animosity from the patients.
We emphasize that the steps taken and procedures we used
help to protect us in the event of legal actions.
It is important as to how selection of ESRD patients is
conducted among those who are candidates for receiving a
suboptimal kidney. In contrast to marginal kidneys, which
are usually transplanted in elderly recipients, suboptimal
kidneys may also be advantageous in young patients,
although this requires consideration of factors such as
weight, vascular and excretory tract conditions, and the
speciﬁcs of the suboptimal organ [30e33]. Kidneys with
quantitatively reduced nephron mass have shown better
results when transplanted in a recipient of smaller size than
the donor, preferably women [6,34].
One socioeconomic aspect that should also be considered
is how utilization of suboptimal kidneys offers certain eco-
nomic advantages, whereas missed utilization of an organ
already obtained during multiorgan harvesting is a waste of
economic resources within the national health system. That
is, in cases where the organ has ultimately not been used for
transplant, the economic resources used could have been
allocated elsewhere.CONCLUSIONS
The utilization of suboptimal kidneys is still a controversial
subject. On the one hand, use of such organs seems to go
against the right of the patient to receive the best treatment
available; on the other hand, the lack of donors and evi-
dence of beneﬁts of transplantation, even with suboptimal
kidneys, on a patient’s quality of life and its superiority to
dialysis, justify the use of such organs.
The ethical problems related to the use of suboptimal
kidneys will not be resolved until the time when optimal
kidneys are available for every patient in ESRD; however,
this is very unlikely, especially until law regarding donation
in our country will leave it to the altruistic consent of the
donor or of his/her relatives. So, in this setting of lack ofavailable organs, all resources should be used, including
suboptimal kidneys, leaving autonomy to the potential
recipient whether to accept or refuse the donation.
For successful transplantation of a suboptimal kidney it is
necessary to establish a proper match between organ and
recipient. Patient selection plays a fundamental role: the
recipient must be of lower weight and have less muscle mass
than the donor, so as to be adequate for the kidney’s
working parenchyma transplanted. Those characteristics are
generally identiﬁed in female recipient. The transplant of a
suboptimal kidney offers more technical difﬁculties than a
standard organ transplant and exposes the patient to a
higher risk of surgical complications, so the transplant must
take place in hospitals fully prepared for this type of surgery
and must be performed by experienced transplant surgeons.
Only in this way can the surgical risk related to the utiliza-
tion of suboptimal kidneys be acceptable.
The distinction between optimal and suboptimal kidneys
can lead to legal issues, such as the civil responsibility related
to incomplete information from doctor to patient. A correct
acquisition of consent is fundamental to decrease the risks of
legal actions. Doctors must provide complete and honest in-
formation about the risks related to use of suboptimal kidneys
to allow the patients to evaluate the risks and beneﬁts of
transplant of such organs and to take their decision in com-
plete autonomy and freedom. Negligent information before
consent may lead to civil and penal action against the surgeon.
Under such circumstances doctors play an essential role
by providing correct and complete information to the
recipient about the risks and beneﬁts related to receiving
the speciﬁc suboptimal kidney in relation to the recipient’s
clinical condition. The patient, once correctly informed, can
then make an autonomous decision as to whether to accept
or refuse donation.
We believe that the use of suboptimal kidneys should be
expanded because it has shown good clinical results and
carries fewer potential ethical issues than use of marginal
kidneys. In our view, this could also be be an option for
young patients affected by ESRD.REFERENCES
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